Clinical Coagulation, Malmö

621 – 630 of 648

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000575?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

1998
Mark The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
Zöller, Bengt ^LU ; Svensson, P.J. ^LU ; Dahlbäck, Björn ^LU and Hillarp, A. ^LU (1998) In Blood 91(6). p.2210-2211
- Contribution to journal › Letter
Mark The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
Zöller, Bengt ^LU ; Svensson, P J ^LU ; Dahlbäck, Björn ^LU and Hillarp, A ^LU (1998) In Blood 91(6). p.1-2210
- Contribution to journal › Letter
1997
Mark No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products
Astermark, Jan ^LU ; Ekman, Maj ^LU and Berntorp, Erik ^LU (1997) In British Journal of Haematology 99(2). p.289-294
- Contribution to journal › Article
Mark Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study
Lindeberg, Staffan ^LU ; Berntorp, Erik ^LU ; Nilsson-Ehle, Peter ^LU ; Terent, Andreas and Vessby, Bengt (1997) In American Journal of Clinical Nutrition 66(4). p.845-852
- Contribution to journal › Article
Mark Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia
Carlsson, Maj ^LU (1997)
- Thesis › Doctoral thesis (compilation)
Mark Resistance to activated protein C a novel risk factor for venous thrombosis
Svensson, Peter ^LU (1997)
- Thesis › Doctoral thesis (compilation)
Mark Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
Carlsson, M ; Berntorp, E. ^LU ; Björkman, S ; Lethagen, S. ^LU and Ljung, R. ^LU (1997) In Haemophilia 3(2). p.96-101
- Contribution to journal › Article
Mark Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
Svensson, Peter ^LU ; Zöller, Bengt ^LU and Dahlbäck, Björn ^LU (1997) In Thrombosis and Haemostasis 77(2). p.332-335
- Contribution to journal › Article
Mark Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis
Zöller, Bengt ^LU ; Hillarp, Andreas ^LU ; Berntorp, E ^LU and Dahlbäck, Björn ^LU (1997) In Annual Review of Medicine 48. p.45-58
- Contribution to journal › Article
Mark The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
Svensson, P.J. ^LU ; Zöller, B. ^LU ; Mattiasson, I. ^LU and Dahlbäck, B. ^LU (1997) In Journal of Internal Medicine 241(5). p.379-385
- Contribution to journal › Article

Publications

Open access (%)

Authors/Editors

(329)
(147)
(135)
(49)
(37)
(36)
(28)
(27)
(26)
(23)
(21)
(21)
(20)
(19)
(19)
(18)
(18)
(17)
(16)
(16)
(14)
(13)
(13)
(11)
(11)
(10)
(10)
(9)
(9)
(9)
(8)
(8)
(8)
(7)
(7)
(7)
(7)
(7)
(7)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(5)
(5)
(5)
(5)

your query:: Remove department: Clinical Coagulation, Malmö